Randomized, placebo‐controlled, double‐blind phase I trial of co‐administered pyronaridine and piperaquine in healthy adults of sub‐Saharan origin
Abstract Drug resistance to sulfadoxine‐pyrimethamine and amodiaquine threatens the efficacy of malaria chemoprevention interventions in children and pregnant women. Combining pyronaridine (PYR) and piperaquine (PQP), both components of approved antimalarial therapies, has the potential to protect v...
Saved in:
Main Authors: | Andrea Kuemmerle (Author), Denis Gossen (Author), Annick Janin (Author), Andrew Stokes (Author), Nada Abla (Author), Maja Szramowska (Author), Ulrike Lorch (Author), Myriam El Gaaloul (Author), Isabelle Borghini‐Fuhrer (Author), Stephan Chalon (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reproductive and endocrine effects of artemisinin, piperaquine, and artemisinin-piperaquine combination in rats
by: Xiaobo Li, et al.
Published: (2022) -
Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.
by: Erik Koehne, et al.
Published: (2021) -
Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.
by: Erik Koehne, et al.
Published: (2022) -
Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma
by: Erik Koehne, et al.
Published: (2022) -
Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.
by: Thomas R Lane, et al.
Published: (2019)